Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients

Completed

Conditions studied: Chronic Kidney Disease

In brief

The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.

Key facts

Study ID

NCT01364779

Run by

Northwell Health

People needed

15

Starts

2010-04-01

Expected to finish

2012-03-01

Last updated by the study team

2013-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with known structural kidney disease as evident by history or by urinalysis and CKD stage III or IV determined by MDRD formula and who are taking aspirin.

You may not qualify if…

• Younger than 18 years of age.
• Bleeding disorder or myeloproliferative disorders.
• Thrombocytopenia with platelets < 100.000.
• Malignancy.
• Acute hemorrhagic disease.
• A recent history of receipt of platelet glycoprotein IIb/IIIa blockers.
• Liver disease as evident by abnormal liver function and total bilirubin > 2mg/dl.
• use of anticoagulation.

Where it is running

• staten island University Hospital nephrology clinic — Staten Island, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.